What is NDC 47335-736?

47335-736 is the product NDC for Bupropion hydrochloride, Bupropion hydrochloride 100 mg/1 tablet, film coated, extended release, listed with the FDA by Sun Pharmaceutical Industries, Inc.. It has 4 package NDCs, shown above in 10- and 11-digit form.

Sun Pharmaceutical Industries, Inc., NDC labeler code 47335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Bupropion hydrochloride?

171 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Bupropion hydrochloride NDC 47335-736

NDC codes

FDA NDC Directory

Product NDC (as listed)47335-736Labeler and product segments. Claims need a package NDC.

Product NDC at billing width47335-0736Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
47335-736-08	4733507360847335073608	100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47335-736-08)Marketed from Mar 1, 2020
47335-736-13	4733507361347335073613	500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47335-736-13)Marketed from Mar 1, 2020
47335-736-86	4733507368647335073686	60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47335-736-86)Marketed from Mar 1, 2020
47335-736-88	4733507368847335073688	100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47335-736-88)Marketed from Mar 1, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Bupropion hydrochloride
Generic name (nonproprietary): bupropion hydrochloride
Active ingredients: Bupropion hydrochloride — 100 mg/1
Dosage form: Tablet, Film coated, Extended release
Route: Oral
Labeler: Sun Pharmaceutical Industries, Inc.NDC labeler code 47335
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 078866
Marketing start: Mar 1, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Dopamine Uptake Inhibitors (Mechanism)Increased Dopamine Activity (Physiologic effect)Increased Norepinephrine Activity (Physiologic effect)Norepinephrine Uptake Inhibitors (Mechanism)
Identifiers: Product ID 47335-736_b8e6ae63-c5d7-4481-b7b0-17e135670515SPL ID b8e6ae63-c5d7-4481-b7b0-17e135670515SPL set ID 29848192-7de3-4c0d-a822-1268dcf128b0RxCUI 993503, 993518, 993536UNII ZG7E5POY8OUPC 0347335738865, 0347335737868
Pharmacologic class: Aminoketone

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N447335073608 followed by a unit qualifier and the quantity

Package 47335-0736-08. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 9, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

Bupropion hydrochloride extended-release tablets, USP (SR) are indicated for the treatment of major depressive disorder (MDD), as defined by the Diagnostic and Statistical Manual (DSM ) . The efficacy of bupropion in the treatment of a major depressive episode was established in two 4-week controlled inpatient trials and one 6-week controlled outpatient trial of adult subjects with MDD [see Clinical Studies(14)] . The efficacy of bupropion hydrochloride extended-release tablets, USP (SR) in maintaining an antidepressant response for up to 44 weeks following 8 weeks of acute treatment was demonstrated in a placebo-controlled trial [see Clinical Studies (14)] . Bupropion hydrochloride is an am…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 47335-736

What is NDC 47335-736?: 47335-736 is the product NDC for Bupropion hydrochloride, Bupropion hydrochloride 100 mg/1 tablet, film coated, extended release, listed with the FDA by Sun Pharmaceutical Industries, Inc.. It has 4 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Bupropion hydrochloride.
What is the active ingredient?: Bupropion hydrochloride.
Who is the labeler?: Sun Pharmaceutical Industries, Inc., NDC labeler code 47335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Bupropion hydrochloride?: 171 other product NDCs are listed under this name. See all Bupropion hydrochloride NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Bupropion hydrochloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Bupropion hydrochloride	Bupropion hydrochloride 300 mg/1	Tablet, Extended releaseOral	REMEDYREPACK INC.	70518-4739	70518-4739-00
Bupropion Hydrochloride	Bupropion hydrochloride 100 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-1143	67046-1143-03
Bupropion Hydrochloride	Bupropion hydrochloride 150 mg/1	Tablet, Film coated, Extended releaseOral	Aurobindo Pharma Limited	59651-511	59651-0511-0559651-0511-3059651-0511-90
Bupropion Hydrochloride	Bupropion hydrochloride 300 mg/1	Tablet, Film coated, Extended releaseOral	Aurobindo Pharma Limited	59651-512	59651-0512-0559651-0512-3059651-0512-90
Bupropion hydrochloride	Bupropion hydrochloride 150 mg/1	Tablet, Extended releaseOral	Coupler LLC	67046-1273	67046-1273-03
Bupropion hydrochloride	Bupropion hydrochloride 300 mg/1	TabletOral	Unit Dose Solutions, Inc.	87441-014	87441-0014-01
bupropion hydrochloride	Bupropion hydrochloride 150 mg/1	Tablet, Extended releaseOral	REMEDYREPACK INC.	70518-4674	70518-4674-0070518-4674-0170518-4674-02
Bupropion Hydrochloride	Bupropion hydrochloride 75 mg/1	Tablet, Film coatedOral	Amici Pharma, Inc.	69292-601	69292-0601-01
Bupropion Hydrochloride	Bupropion hydrochloride 100 mg/1	Tablet, Film coatedOral	Amici Pharma, Inc.	69292-602	69292-0602-01
bupropion Hydrochloride	Bupropion hydrochloride 100 mg/1	TabletOral	Coupler LLC	67046-1672	67046-1672-03

All 172 Bupropion hydrochloride NDCs

Other NDCs under ANDA 078866

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 078866
Product	Strength	Form · route	Labeler	Product NDC
Bupropion hydrochloride	Bupropion hydrochloride 150 mg/1	Tablet, Film coated, Extended releaseOral	Sun Pharmaceutical Industries, Inc.	47335-737
Bupropion hydrochloride	Bupropion hydrochloride 200 mg/1	Tablet, Film coated, Extended releaseOral	Sun Pharmaceutical Industries, Inc.	47335-738
Bupropion hydrochloride	Bupropion hydrochloride 150 mg/1	Tablet, Film coated, Extended releaseOral	Proficient Rx LP	63187-052
Bupropion hydrochloride	Bupropion hydrochloride 100 mg/1	Tablet, Film coated, Extended releaseOral	Proficient Rx LP	63187-176
Bupropion hydrochloride	Bupropion hydrochloride 200 mg/1	Tablet, Film coated, Extended releaseOral	Proficient Rx LP	63187-178